Search research articles
Contact Us
Filters
Showing results (51-60 of 129) with videos related to
Page
of 13
Sort By:
Journal of Clinical Psychopharmacology
|
February 19, 2021
Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series
María Gómez-Sousa, Daniel F Jiménez-Garrido, Genís Ona, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports
Emerson Arcoverde Nunes, Tatiana M N Rezende, Silvio L Morais, et al.
Frontiers in Pharmacology
|
February 26, 2014
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
Raquel Levin, Fernanda F Peres, Valéria Almeida, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 10, 2020
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G Dos Santos, Francisco S Guimarães, José Alexandre S Crippa, et al.
Therapeutic Advances in Psychopharmacology
|
May 9, 2019
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
Juliana M Rocha, Flávia L Osório, José Alexandre S Crippa, et al.
CNS Neuroscience & Therapeutics
|
April 16, 2018
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
Mariana C Diana, Fernanda F Peres, Veronica Justi, et al.
British Journal of Pharmacology
|
February 6, 2024
Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT<sub>2A</sub> and 5-HT<sub>1A</sub> receptors
Isabel Werle, Laura M M Nascimento, Aymee L A Dos Santos, et al.
Biomolecules
|
November 11, 2022
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T L Guerra, Glen B Baker, et al.
Scientific Reports
|
September 11, 2023
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
José Carlos Bouso, Dóra Révész, Genís Ona, et al.
Expert Opinion on Drug Safety
|
March 18, 2022
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 129) with videos related to
Sort By:
Page
of 13
Journal of Clinical Psychopharmacology
|
February 19, 2021
Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series
María Gómez-Sousa, Daniel F Jiménez-Garrido, Genís Ona, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports
Emerson Arcoverde Nunes, Tatiana M N Rezende, Silvio L Morais, et al.
Frontiers in Pharmacology
|
February 26, 2014
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
Raquel Levin, Fernanda F Peres, Valéria Almeida, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 10, 2020
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G Dos Santos, Francisco S Guimarães, José Alexandre S Crippa, et al.
Therapeutic Advances in Psychopharmacology
|
May 9, 2019
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
Juliana M Rocha, Flávia L Osório, José Alexandre S Crippa, et al.
CNS Neuroscience & Therapeutics
|
April 16, 2018
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
Mariana C Diana, Fernanda F Peres, Veronica Justi, et al.
British Journal of Pharmacology
|
February 6, 2024
Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT<sub>2A</sub> and 5-HT<sub>1A</sub> receptors
Isabel Werle, Laura M M Nascimento, Aymee L A Dos Santos, et al.
Biomolecules
|
November 11, 2022
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T L Guerra, Glen B Baker, et al.
Scientific Reports
|
September 11, 2023
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
José Carlos Bouso, Dóra Révész, Genís Ona, et al.
Expert Opinion on Drug Safety
|
March 18, 2022
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker, et al.
Page
of 13